Simm530, a novel and highly selective c-Met inhibitor, blocks c-Met-stimulated signaling and neoplastic activities

Ying Wang(Leiden University Medical Center), Meiyu Geng(Shanghai Institute of Materia Medica)
Oncotarget
May 13, 2016
Cited by 10


Related Papers